- Tigecycline (TG) is a new antibiotic used to treat methicillin-resistant Staphylococcus aureus (MRSA) infections, and the T.E.S.T. study globally monitors bacterial resistance to TG in MRSA.
- A comprehensive review analyzed over 2500 articles related to TG and MRSA, ultimately including 48 relevant studies, primarily focusing on blood and respiratory samples.
- Although microbial resistance to TG is currently low, ongoing evaluation of its use against MRSA and other pathogens is essential to ensure effective treatment.